1. CRISPR-Cas9 in basic and translational aspects of cancer therapy

Maryam Samareh Salavatipour , Zahra Poursalehi, Negin Hosseini Rouzbahani, Sohaib Mohammadyar, Mohammad Vasei*

Bioimpacts. 2024;14(6): 30087. doi: 10.34172/bi.2024.30087

PMCID: PMC11530967 PMID: 39493894 Scopus ID: 85209235663

Article

PDF

Full Text

XML

Cited By:

Original Article

2. Saponin conjugation improves p-CRISPR delivery by polyethylenimine modified carbon dots

Ali Hamad Abd Kelkawi , Seyede Mahtab Kamrani Mousavi, Akbar Hasanzadeh, Sara Saeedi, Behjat Kheiri Yeganeh Azar, Babak Kamali, Seyyed Emad Hooshmand, Mohadese Rastgoo Korande, Michael R Hamblin, Jawdat N. Gaaib, Mahdi Karimi*

Bioimpacts. 2026;16: 33272 | Published on: 2026 Aug 19. doi: 10.34172/bi.33272

Article

PDF

Suppl 1

XML

Cited By:

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Policies Editorial Board Policy Abstracting and Indexing Archive

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences.
Acceptance rate (2024): 19%
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded; Google Scholar; SJR; Essential Science Indicators; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO
Member of
Follower of ICMJE
Permission: Creative Commons